Evidence map›Paper›PMID 30108453›Full record

ArticleSaudi journal of biological sciences2018

Anti-tumor and anti-metastatic roles of cordycepin, one bioactive compound of

Ye Jin, Xue Meng, Zhidong Qiu, Yanping Su, Peng Yu, Peng Qu

Open access · hybridAbstract read
In one paragraph

Article in Saudi journal of biological sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.

0numbers the graph read from it
0cells of the map it votes in
33citing papers in PubMed
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

33 citing papers in PubMed, 96 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Gels (Basel, Switzerland) · 2025
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Hydrophobin GeneInternational journal of molecular sciences · 2023
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Antileukaemic Cell Proliferation and Cytotoxic Activity of Edible Golden Cordyceps (Evidence-based complementary and alternative medicine : eCAM · 2022
    Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Ye JinDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, Jilin, China.
Xue MengDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, Jilin, China.
Zhidong QiuDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, Jilin, China.
Yanping SuDepartment of Histology and Embryology, Taishan Medical College, Taian, Shangdong, China.
Peng YuDepartment of Pharmacy, Changchun University of Chinese Medicine, Changchun, Jilin, China.
Peng QuNational Cancer Institute, National Institutes of Health, Frederick, MD, USA.
Changchun University of Chinese Medicine · CNNational Cancer Institute · USTaishan Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Public interest in complementary and alternative medicine has been increased worldwide, due to its wide applications in cancer prevention and treatment. Cordycepin is one of the most common and crucial types of complementary and alternative medicine. Cordycepin (3'-deoxyadenosine), a derivative of adenosine, was first isolated from medicine drug

Indexed as

Anti-metastasisAnti-tumorCordycepin

Identifiers

PMID30108453
PMCPMC6088102
OpenAlexW2804044064

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.